Regeneron Pharmaceuticals Inc
-
Health News
Viking stock doubled Tuesday. Here’s where the next moves in the obesity space could come from
[ad_1] Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but given the vast and…
Read More » -
Health News
Oprah’s flip on weight loss drugs is a sign of what’s to come for the ‘Ozempic trade’ in 2024
[ad_1] For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described it in declaring…
Read More » -
Health News
If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space
[ad_1] Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk…
Read More » -
Health News
These stocks are trying to solve a major shortcoming of weight loss drugs: Shrinking muscle mass
[ad_1] One of the downsides of taking new anti-obesity medications is that patients tend to lose lean muscle mass along…
Read More » -
Health News
Here are some of the companies saying weight loss drugs could impact their business
[ad_1] The impact of new weight loss treatments is being felt well beyond the health-care industry . Analysts used the…
Read More »